Tactile Systems Technology (TCMD) Capital Expenditures Growth (3y) (2018 - 2026)
Tactile Systems Technology (TCMD) Capital Expenditures Growth (3y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.86 Bn | 176.56 Bn | 6.27 Bn | 1.64% |
| 2 | Stryker | 128.65 Bn | 125.78 Bn | 3.81 Bn | 8.49% |
| 3 | Medtronic | 108.75 Bn | 99.53 Bn | 6.41 Bn | 8.89% |
| 4 | Boston Scientific | 68.34 Bn | 66.89 Bn | 3.61 Bn | 16.83% |
| 5 | Edwards Lifesciences | 48.33 Bn | 44.65 Bn | 1.29 Bn | 1.81% |
| 6 | GE HealthCare Technologies | 28.35 Bn | 26.07 Bn | 1.98 Bn | 7.57% |
| 7 | Dexcom | 28.33 Bn | 27.21 Bn | 750.30 Mn | 0.84% |
| 8 | Smith & Nephew | 26.90 Bn | 26.32 Bn | - | - |
| 9 | Koninklijke Philips | 25.45 Bn | 22.33 Bn | 2.07 Bn | 2.15% |
| 10 | Tactile Systems Technology | 629.45 Mn | 539.26 Mn | 57.61 Mn | 50.47% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 50.47% |
| Dec 31, 2025 | 118.34% |
| Sep 30, 2025 | -7.11% |
| Jun 30, 2025 | 22.65% |
| Mar 31, 2025 | 42.49% |
| Dec 31, 2024 | -19.51% |
| Sep 30, 2024 | 15.41% |
| Jun 30, 2024 | 12.20% |
| Mar 31, 2024 | 24.63% |
| Dec 31, 2023 | 27.33% |
| Sep 30, 2023 | -26.59% |
| Jun 30, 2023 | 38.48% |
| Mar 31, 2023 | -12.36% |
| Dec 31, 2022 | -65.27% |
| Sep 30, 2022 | -17.75% |
| Jun 30, 2022 | -42.07% |
| Mar 31, 2022 | -43.62% |
| Dec 31, 2021 | -21.34% |
| Sep 30, 2021 | -3.33% |
| Jun 30, 2021 | -34.64% |